The company’s main business segment is the health care products, which are available in the Greek market as well as East Europe, Middle East and Central Asia.
The aim of the company is the development and trading of pharmaceutical products, with a strong position in branded generics area.
The company’s commitment is the protection of public health and the improvement of the human’s life quality.
Norma Hellas S.A. is the marketing authorization holder of more than 70 pharmaceutical products and launches more than 46 of them. New products are under approval through national as well as mutual and decentralized procedures. Moreover new products and advanced pharmaceutical forms are under development in research centers in Greece and Europe.